Anaplastic large cell lymphoma (ALCL), a distinct subtype of T-cell non-Hodgkin lymphoma, has been the subject of vigorous research efforts over recent years. Investigations have focused on ...

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...

The Gold Star family of Sgt. Jack Stillman is anxiously anticipating a ceremony on post that will dedicate the ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

This trial compared ofatumumab with rituximab for people with diffuse large B cell or follicular lymphoma.